血清神经丝轻链蛋白监测多发性硬化疾病活动
研究纳入373名参与者(286例多发性硬化、45例其他神经疾病、42例健康对照),检测配对血清与脑脊液神经丝轻链蛋白(NFL)浓度。结果显示血清与脑脊液NFL高度相关(r=0.62),疾病活动期血清NFL显著升高,疾病修正治疗(DMT)可降低血清NFL水平。
要点
- 血清与脑脊液NFL浓度高度相关,可用血液采样替代脑脊液检测。
- 复发缓解型和进展型多发性硬化患者血清NFL均显著高于健康对照。
- DMT治疗可显著降低血清NFL水平,复发或影像学活动者血清NFL更高。
核心结论
- 血清与脑脊液NFL水平高度相关,血液采样可替代脑脊液检测该标志物。
- 疾病活动和DMT对血清与脑脊液NFL浓度的影响相似。
- 反复检测外周血NFL可能成为多发性硬化监测的新手段。
研究设计与样本
- 测量373名参与者的配对血清和脑脊液样本(n=521),其中286例多发性硬化、45例其他神经疾病、42例健康对照。
- 138例多发性硬化患者在DMT治疗前后获取血清和脑脊液样本,中位间隔12个月。
- 脑脊液NFL用UmanDiagnostics NF-light酶联免疫吸附试验测定,血清NFL用内部超灵敏单分子阵列试验测定。
主要发现
- 多发性硬化中血清与脑脊液NFL相关性r=0.62(p<0.001)。
- 复发缓解型多发性硬化血清NFL为16.9 ng/L,进展型为23 ng/L,均显著高于健康对照的10.5 ng/L(p<0.001)。
- DMT治疗将中位血清NFL从18.6 ng/L(IQR 12.6-32.7)降至15.7 ng/L(IQR 9.6-22.7)(p<0.001)。
- 复发或影像学活动患者血清NFL显著高于缓解期(p<0.001)或无新发MRI病灶者(p<0.001)。
临床怎么用
- 可考虑用血清NFL替代脑脊液NFL监测多发性硬化轴索损伤。
- 血清NFL可用于评估疾病活动性和DMT治疗反应。
- 重复检测外周血NFL有助于多发性硬化的动态监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the effects of disease activity, disability, and disease-modifying therapies (DMTs) on serum neurofilament light (NFL) and the correlation between NFL concentrations in serum and CSF in multiple sclerosis (MS). METHODS: NFL concentrations were measured in paired serum and CSF samples (n = 521) from 373 participants: 286 had MS, 45 had other neurologic conditions, and 42 were healthy controls (HCs). In 138 patients with MS, the serum and CSF samples were obtained before and after DMT treatment with a median interval of 12 months. The CSF NFL concentration was measured with the UmanDiagnostics NF-light enzyme-linked immunosorbent assay. The serum NFL concentration was measured with an in-house ultrasensitive single-molecule array assay. RESULTS: In MS, the correlation between serum and CSF NFL was r = 0.62 (p < 0.001). Serum concentrations were significantly higher in patients with relapsing-remitting MS (16.9 ng/L) and in patients with progressive MS (23 ng/L) than in HCs (10.5 ng/L, p < 0.001 and p < 0.001, respectively). Treatment with DMT reduced median serum NFL levels from 18.6 (interquartile range [IQR] 12.6-32.7) ng/L to 15.7 (IQR 9.6-22.7) ng/L (p < 0.001). Patients with relapse or with radiologic activity had significantly higher serum NFL levels than those in remission (p < 0.001) or those without new lesions on MRI (p < 0.001). CONCLUSIONS: Serum and CSF NFL levels were highly correlated, indicating that blood sampling can replace CSF taps for this particular marker. Disease activity and DMT had similar effects on serum and CSF NFL concentrations. Repeated NFL determinations in peripheral blood for detecting axonal damage may represent new possibilities in MS monitoring.
引用
- Novakova L, Zetterberg H, Sundström P, et al. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein. Neurology. 2017. PMID: 29079686. doi:10.1212/WNL.0000000000004683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。